For that reason, please set aside enough time for a 1-hour long conversation regarding your health history, previous weight loss attempts, and lab or blood work reviews
PMID: 23736544
GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials
During the study period, the researchers tracked which of the 524,817 participants in the first group developed alcohol, cannabis, cocaine, nicotine, opioid or other substance use disorder
(Sartain, 2024) By adjusting your dose gradually, you give your body more time to adjust to the change in medication, minimizing the risk of rebound weight gain
Xue X, Ren Z, Zhang A, Yang Q, Zhang W, Liu F (2016) Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials